Term
| What do we use to analyze proteins? |
|
Definition
Western Blot Analysis
Proteins isolated from cell extracts are separated according to size and charge by polyacrylamide gel elecrophoresis, transferred to a membrane and detected by antibodies. |
|
|
Term
| What does CT mean in quantitative PCR? |
|
Definition
| CT is the point at which the fluorescent signal, ie, PCR product, is first detected. (PCR cycle number vs. signal intensity on a graph). |
|
|
Term
What methods do we use to detect copy number changes (deletions and duplications in genomic DNA)...
Just give the 4 names of the tests. |
|
Definition
- Quantitative PCR
- Multiplex ligation-dependent probe amplification (MLPA)
- Fluorescence in situ hybridization (FISH)
- Array comparative genomic hybridization [a(CGH)]
|
|
|
Term
What are 3 kinds of expression (RNA) testing?
What research and clinical uses do they have? |
|
Definition
1. Northern Blot
2. Reverse Transcriptase PCR (RT-PCR)
3. Expression Arrays
Research:
1. Characterize diseased and normal tissue to elucidate molecular pathogenesis.
2. Identify genes associated w/ a disorder, assuming that genes w/ altered expression relative to control tissue play a role in that disease.
Clinical: Characterize tumors for prognosis and match the specific chemo w/ the specific type of tumor.
|
|
|
Term
a(CGH)
1. What it stands for
2. What it's used for
3. How it's done
|
|
Definition
1. Array comparative genomic hybridization
2. Method to detect copy # changes in genomic (g) DNA. Can detect deletions/duplications that are ~100 kb or larger in size, looks at entire genome.
3. Patient and control DNA's labled with different fluorescent molecules, then co-hybridized in equal amts to the array of DNA probes. Slide is then imaged by computer. Normal karyotype - each probe hybridizes equally to test *green* and reference *red* DNA. Result is yellow, 1:1 ratio. Deletions/duplications - change in the ration between red and green.
|
|
|
Term
FISH
1. What it stands for
2. What it's used for
3. How it's done |
|
Definition
1. Fluorescense in situ Hybridization
2. Method to detect copy # changes in gDNA. Detects deletions that are for ~100 kb to several Mb in size, but only a few loci are tested at a time.
3. Performed on metaphase chromasomes. Chromasome DNA is denatured on a microscope slide, then hybridized with a fluorescent probe.
|
|
|
Term
MLPA
1. What it stands for
2. What it's used for
3. How it's done. |
|
Definition
1. Multiple ligation-dependent probe amplification
2. Method to detect DNA copy # changes in gDNA
3. a) 1/2 probes hybridize next to each other at their complementary target regions in gDNA.
b) Probes joined by ligase, amplified by PCR using common adapters.
c) Amount of final PCR product for each probe corresponds to amount (copy #) of the target region in the gDNA.
|
|
|
Term
Quantitative PCR
1. What it's used for
2. How it's done |
|
Definition
1. Used to detect copy # changes
2. a) DNA or RNA of interest is amplified w/ fluorescent probe or DNA-binding dye. Intensity of fluorescent signal generated increases in proportion to the amout of PCR product produced.
b) Fluorescent signal intensity measured is then graphed on an amplification chart to determine CT (point when fluorescence signal, or PCR product, is first detected).
c) CT values are compared against a standard curve to determine the amount of DNA or RNA in a patient's sample.
|
|
|
Term
|
Definition
Example of a PCR stand alone test:
- The forward primer is designed at it's 3' end to match allele B, but not A. If B is present in target DNA, an amplicon will be produced in PCR replication. A complimentary ARMSPCR is also performed; the forward primer is designed to match A allele and not B. |
|
|
Term
PCR
1. How it's done
2. What it's used for |
|
Definition
1. Produces millions of copies of short DNA through repeated cycles of:
denaturation
annealing
elongation
2. a) generate enough DNA to perform a test like sequence analysis or mutation scanning; b) be a test unto itself, like allele specific amplification or trinucleotide quantification; c) good for diseases with common mutations |
|
|
Term
Kinds of nucleotide substitutions:
|
|
Definition
Missense mutations: aa substitutions
Nonsense mutations: premature stop codons
RNA processing mutations
Splice site mutations
regulatory mutations |
|
|
Term
|
Definition
| Three homologous chromasomes in each set (69 in humans). |
|
|
Term
| What enzyme catalyzes DNA transcription to make mRNA? |
|
Definition
|
|
Term
| What is Pol II composed of? |
|
Definition
| 12 different proteins, Rpb1 - Rpb12, the largest of which is Rpb1. Rpb1 has a long C-terminal domain that tethers RNA processing proteins, including cap factors (CF), splicing factors, (SF), cleavage and polyadenylation factors (CPF) and termination factors (TF). These bind and modify mRNA as it exits Pol II. |
|
|
Term
| How is mRNA capped? What is the cap made of? What does capping do? |
|
Definition
As mRNA leaves Pol II, the cap is added to the 5' end by factors bound to Rpb-CTD.
Cap is made of methylated guanosine residue, attached backward to the first mRNA nucleotide, 5' to 5' triphosphate linkage. This protects the mRNA from degredation.
Cap is also a binding site for proteins that facilitate:
Splicing of pre-mRNA
Transport of the mRNA to the cytoplasm
Translation of the mRNA by ribosomes
|
|
|
Term
| Major components in the nucleus |
|
Definition
| Nucleoli, nuclear matrix, nuclear membrane, nucleoli, chromatin |
|
|
Term
|
Definition
Where ribosomal DNA is transcribed into rRNA.
Large, dark staining region near the center of the nucleus.
Consists of up to 10 chromasome tips, each of which have a nucleorlar organizer of ~ 40 rRNA genes each, giving up to ~400 rRNA genes/cell.
Organizers start as several small nucleoli, coalese into a single nucleolus.
Prominent during interphase. |
|
|
Term
|
Definition
| "Copies" of chromasomes arising from DNA replication early in the cell cycle. (These become the chromasomes of the daughter cells.) |
|
|
Term
|
Definition
Meiotic error in which homologs (meiosis I) or chromatids (meiosis II) fail to separate, resulting in abnormal chromasome segregation on the gametes.
A. Full Monosomies: virtually always lethal. Monosomy X is a partial exception.
B. Full Trisomies: Generally lethal. Exceptions: 13, 18, 21, sex chromasomes. |
|
|
Term
|
Definition
| The presence of 2 or more different chromasome complements in an individual, which can result from nondisjunction in mitosis or "trisomy rescue." |
|
|
Term
|
Definition
| The postzygotic loss of an extra chromasome, resulting in reversion of a trisomic cell to the disomic state. |
|
|
Term
|
Definition
| An exchange of material between two non-homologous chromasomes. |
|
|
Term
|
Definition
| A translocation with no net gain or loss of genetic material. |
|
|
Term
|
Definition
| A translocation that results in partial monosomy and/or trisomy. |
|
|
Term
| Robertsonian Translocation |
|
Definition
| A fusion of the long arms of 2 acrocentric chromasomes. (4 - 5% cases of Down's are due to Robertsonian translocaitons between chromasome 21 and chromasome 13, 14, or 15. |
|
|
Term
|
Definition
| Loss of some chromasomal material resulting in partial monosomy. |
|
|
Term
|
Definition
| Presence of an extra copy of a portion of a chormasome resulting in a partial trisomy. |
|
|
Term
|
Definition
| Rearrangement of chromasomal material in which a portion is placed "upside down" as a result of 2 breaks in that chromasome. |
|
|
Term
|
Definition
| Excess or deficiency of a portion of a chromasome as a result of structural rearrangement. |
|
|
Term
|
Definition
| Any abnormal nuber of chromasomes (other than 46 in humans) |
|
|
Term
|
Definition
| Having one less than the normal number of chromosomes (eg: 45 in humans). |
|
|
Term
|
Definition
| Having onme more than the normal number of chromasomes (eg: 47 in humans). |
|
|
Term
|
Definition
| Normal number of chromasomes in a gamete (23 in humans). |
|
|
Term
|
Definition
| Normal number of chromasomes in somatic cells (46 in humans). |
|
|
Term
| Indictations for cytogenetic analysis |
|
Definition
- Multiple congenital abnormalities
- Presumed Downs, other well known autosomal trisomy
- Genital ambiguity
- Primary amenorrhea
- Short stature in females
- Small testes, delayed pubery in males
- Stillborn infant
- Recurrent stillborns
- Prenatal diagnosis assessment
- Indentification of translocation carriers
|
|
|
Term
Klinefelter Syndrome
Diagnosis |
|
Definition
- Incidentally on amnio/CVS
- Phenotype at puberty
- Infertility in adulthood
- Some go undiagnosed
|
|
|
Term
Klinefelter Syndrome
Genetics |
|
Definition
- Incidence: 1/600 - 1/1000
- Mosaic (eg: 46, XY / 46, XYY) - 10%
- Poly-X (eg: XXXY) ~10%
- Meiotic nondisjunction, maternal > paternal (slight)
- Weak maternal age effect (vs. Down)
|
|
|
Term
Kleinfelter Syndrome
Growth and Development |
|
Definition
- Normal through age 5, then tall with long legs
- Slight tendency for delays in motor/language development, mild reading difficulties - MOST DEVELOP NORMALLY.
- Sensory-motor integration problems for school age
- Verbal skills lag non-verbal skills by age 4
- Slightly greater than 50% mild reading difficulty
- Avg verbal IQ: 90
- Avg IQ: 103
|
|
|
Term
Kleinfelter Syndrome
Medical Issues |
|
Definition
- Malignancy: Breast cancer more common than in 46, XY males, mediastinal germ cell tumors < 1%.
- Cardiovascular: Increased risk of mitral valve prolapse, DVT, leg ulcers, hypercholesterolemia
- Immunologic: Increased lupus, diabetes, rheumatoid arthritis, thyroid disease.
|
|
|
Term
Klinefelter's Syndrome
Dispelling Myths |
|
Definition
NO
Consistent alteration of body fat distribution
Increase in aberrant sexual behavior
Increase in homosexuality |
|
|
Term
Turner Syndrome
Birth Defects |
|
Definition
- Congenital heart disease
- Kidney structural abnormality
- Lymphedema
- Cystic Hygroma (jugulolymphatic obstruction sequence)
- Nuchal redundancy
|
|
|
Term
Turner Syndrome
Natural History |
|
Definition
- Small stature not detected until after 5, secondary to SHOZ hemizygosity
- Ovarian failure leads to failure to pubertal development, primary amenorrhea, infertility
- Development - NOT associated with retardation but mild learning disabilities, including impairment of visual/spacial functioning.
|
|
|
Term
Turner Syndrome
General Information |
|
Definition
|
|
Term
| Cells require nucleotides for: |
|
Definition
- Synthesis of DNA and RNA
- Energy metabolism (ATP)
- Intracellular signaling (cAMP, cGMP, GTP)
- Coenzymes (especially adneosine derivitives)
- Activating metabolic intermediates (eg. aminoacly-AMP)
|
|
|
Term
| What are nucleotide kinases? |
|
Definition
| An enzyme that all cells have that converts NMP's and NDP's back into NTP's. |
|
|
Term
| What are nucleoside kinases? |
|
Definition
| Enzymes that convert ribonucleosides into ribonucleotides - they produce NMP's |
|
|
Term
| What happens when AMP is present in excess in the cell? |
|
Definition
It's usually hydrolyzed to hypoxanthine, ammonia and ribose-1-phospate by the following reaction in RBC's:
H20 ->Pi H20 -> NH3
AMP -------------> A---------->
phosphatase adenosine deaminase
Pi -> ribose 1-P
I ----------------> hypoxanthine
nucleoside phoshorylase |
|
|
Term
| How is DNA damage handled in the cell? (3 ways) |
|
Definition
1. DNA pol stops at site of damage, DNA synthesis arrested, leading to apoptosis. DNA POL ARREST
2. DNA pol falls off site of damage, special DNA pol for that kind of damage comes on and inserts the right nucleotide opposite the site of damage. Replicative DNA pol hops back on - no mutation. (ERROR-FREE BYPASS)
3. Special DNA pol inserts random nucleotide opposite of site of damage, mutation created. Most dangerous. (ERROR-PRONE BYPASS). |
|
|
Term
Important mechanisms of DNA damage
Depurination |
|
Definition
Spontaneous hydrolysis of glycosidic linkage between ribose and A or G. Induced by alkylating agents like chemo drugs. Loss of G most common. Special DNA Rev 1 inserts dCMP opposite missing base, usually averting a mutation. |
|
|
Term
Important mechanisms of DNA damage
Deamination |
|
Definition
Mostly cytosine. Occurs spontaneously @ low frequency, increased in rate by some chemicals. Deaminated bases have altered pairing properties, can cause substitutions upon replication. EX: Deamination of C creates U, which pairs with A rather than G. Repair pathway exists to remove U from DNA. |
|
|
Term
Important mechanisms of DNA damage
Ultraviolet (UV) Radiation |
|
Definition
| Causes covalent joining of adjacent pyrimidine bases, esp. T residues, called thymine dimers. Thymine dimers stop replicative DNA pol, bypassed by specialized DNA pol. |
|
|
Term
Important mechanisms of DNA damage
Oxidation |
|
Definition
| Oxidation occurs by reactive oxygen species (ROS) generated by normal cellular metabolism, significant source of DNA damage. |
|
|
Term
Important mechanisms of DNA damage
Ionizing radiation |
|
Definition
High-energy radiation generates double-stranded breaks in DNA. Resulting free ends highly reactive, participate in rearrangements, including inversions and translocations. No DNA pol can replicate past double stranded breaks, but they can be repaired by homologous recombination or non-homologous end-joining (NHJE) proteins. |
|
|
Term
| 3 Common features of DNA repair pathways |
|
Definition
1. Portion of hte damaged strand is removed, exposing a single-stranded region that can be as short as one nucleotide or long as hundreds.
2. DNA pol fills in damaged strand adding dNMPs to free 3' OH of gapped strand
3. DNA ligase seals the nick left between the 3' end of newly made DNA and 5' end of the gap, using ATP. |
|
|
Term
| What special nuclease is used to repair depurination? |
|
Definition
| AP (Apurinic) endonuclease - recognizes and excises the remaining deoxyribose-5-phosphate residue. Gap repaired by ligase. |
|
|
Term
| What is the mechanism of cytosine deamination? |
|
Definition
An enzyme - uracil-DNA glycoylase - recognizes & hydrolyses the U from deoxyribose. AP endonuclease then recognizes the abasic site, initiates its repair as in depurination. Use of thymine rather than uracil in DNA allows the detection by the DNA repair enzymes. |
|
|
Term
|
Definition
| Genes that promote unregulated cell growth when active. |
|
|
Term
|
Definition
| Promote regulated cell growth. Mutations give rise to oncogenes, and are usually dominant - only one of two alleles need to be mutated to give rise to oncogenes. |
|
|
Term
|
Definition
| Allow unregulated cell growth only when inactivated or deleted. Keep cell proliferation in check. Mutations are usually recessive, so both alleles must be inactivated or deleted before loss of growth control obtained. |
|
|
Term
| HNPCC, aka Lynch Syndrome |
|
Definition
Non-hereditary non-polyposis colorectal cancer. One gene responsible codes for protein called MSH2, that mediates repair of mismatched bases. Autosomal dominant, but can't get cancer unless both alleles is affected.
Mutations in genes involved in mismatch repair (MSH6, MLH1, PMS2) account for most other cases. Cancer likely results from mismatch repair pathway. |
|
|